Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07323212Not ApplicableCompleted

Occupational Impacts of Resistance Training in Older Adults

Role: collaborator

NCT03861494Not ApplicableCompleted

REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)

Role: lead

NCT05389748Phase 2Unknown

NanO2 for Large Vessel Occlusion Stroke

Role: collaborator

NCT04951518Completed

VAN Assessment Tool in the Treatment of Acute Ischemic Stroke

Role: lead

All 4 trials loaded